The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy

BACKGROUND/AIMS: Dipeptidyl peptidase 4 (DPP4) inhibitors improve glycemic control in type 2 diabetes, however, their influence on the retinal neurovascular unit remains unclear. METHODS: Vasculo- and neuroprotective effects were assessed in experimental diabetic retinopathy and high glucose-cultiva...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Dietrich, Nadine, Kolibabka, Matthias, Busch, Stephanie, Bugert, Petra, Kaiser, Ulrike, Lin, Jihong, Fleming, Thomas, Morcos, Michael, Klein, Thomas, Schlotterer, Andrea, Hammes, Hans-Peter
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5152931/
https://ncbi.nlm.nih.gov/pubmed/27942008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0167853
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados